Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study

作者：Phyo Pyae Nyein, Kathy Petoumenos, Margaret Borok, Nnakelu Eriobu, Nagalingeswaran Kumarasamy, Anchalee Avihingsanon, Iskandar Azwa, Sounkalo Dao, Mohamed Cissé, Nila J. Dharan, Josh Hanson, Gail Matthews · 发表于：Clinical Infectious Diseases · 年份：2024 · DOI：10.1093/cid/ciae256 · 被引用次数：10 · 研究领域：HIV-related health complications and treatments、Blood Pressure and Hypertension Studies、Neurological Complications and Syndromes

In this randomized controlled study, individuals taking dolutegravir+darunavir/ritonavir had greater increases in systolic and diastolic blood pressure than those taking 2 nucleoside reverse-transcriptase inhibitors+darunavir/ritonavir at week-48. The difference remained significant after controlling for confounding factors, including weight gain.